Small Cap Feast
Small Cap Feast – 12 August 2019
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
Rumours and Speculation
SDIC Power Holdings China’s state-backed energy firm has received government approval to issue 10% of its share capital as Global Depositary Receipts (GDRs) on the London Stock Exchange
Freyherr International Group PLC the Medicinal Cannabis holding company established in 2016, is planning to list on the NEX exchange on the 13 August.
Powerhouse Energy Grp (PHE) 0.48p £8.58m
PowerHouse Energy Group plc, the UK technology company pioneering hydrogen production from waste plastic, is pleased to announce it has entered into a collaboration contract with Peel Environmental and Waste2Tricity Limited to seek to develop a minimum of 10 further sites in the UK for DMG® facilities, in addition to the previously announced project at Protos Energy Park.
Peel have a strategy to develop “Plastic Parks” where waste plastics are recycled and regenerated. Peel’s plans involve bringing together potential counterparties for waste, power and hydrogen with a nett negative CO2 contribution for each site.
The PHE DMG® technology has been evaluated by Peel over the past 30 months and Peel have now committed that the DMG® process will be the key component of each facility and a cornerstone of each Peel “Plastic Park”. DMG® will be the enabling technology to ensure there is no plastic to landfill from these sites by regenerating the waste plastic into power and hydrogen.
Peel will be bringing their land bank, industrial real estate and infrastructure support to the consortium. PHE has an agreement with W2T enshrined in the Collaboration Contract under which W2T will act as project developer for each project and Peel will provide support to W2T with ongoing engagement with funders, with the intention of securing funding for the pipeline of 11 projects from institutional investors. PHE will be contracted to each project under development to provide the engineering, delivery, operation and licensing of the DMG® technology.
Thor Mining PLC* (THR) 0.53p £4.52m
The Board of Thor Mining Plc (AIM, ASX: THR) is pleased to announce further positive assay results from the second metallurgical bulk sample drill hole at the company’s wholly owned Molyhil tungsten molybdenum deposit, in the Northern Territory of Australia.
The second of two PQ (85mm) diamond drill holes drilled down plunge of the Molyhil Yacht Club lode to obtain material for production of tungsten and molybdenum concentrate samples has now been assayed.
3.5m @ 1.32%WO3 from 9.5m
10m @ 0.32% Cu from 44m
10m @ 1.32%WO3 from 53m
5m @ 1.74%WO3 from 76m including 2m @ 0.81%Mo from 78m and;
7m @ 1.58%WO3 from 88m including 4m @ 0.44%Mo from 88m
The holes were designed specifically for production of concentrate samples and will not contribute to the mineral resource estimate.
Following the results, Thor has commissioned RPMGlobal to assess the Molyhil Mineral Resource Estimate for the inclusion of copper.
Angling Direct PLC (ANG) 75p £47.82m
Angling Direct plc (AIM: ANG.L), the largest specialist fishing tackle and equipment retailer in the UK, is pleased to announce its trading update for the six months ended 31 July 2019 and that it will publish its interim results on 7 October 2019.
Revenue for the period was in line with management’s expectations, increasing by 21 per cent. to £26.52 m in the six months ended 31 July 2019 (2018: £21.94 m). The Company was delighted to achieve strong store and e-commerce sales, in what has been a challenging period for the wider UK retail sector, demonstrating the success of the Company’s strategic focus on customer experience and service, as well the growing recognition of the Angling Direct brand. The Company expects to report gross margins for the period of 32.1 per cent. and, with margins stronger in June and July, management remain confident in the outcome for the year.
Store expansion remains on track, with the Company’s latest store opening in Leeds on 10 August 2019. This brings the total number of Angling Direct stores across the country to 29 and further enhances the Company’s footprint across the UK. The Leeds store offers a 5,500 sq. ft. display area and is located just two miles south of Leeds city centre, in the City South Retail Park, with easy access via the M621 and A61 arterial road.
Tekcapital plc (TEK) 6.88p £4.3m
Tekcapital Plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from investing in university technology, is very pleased to announce that its portfolio company Salarius ltd. has filed an additional patent application #16/535,703 for MicroSalt® entitled “Improved Low Sodium Salt Composition.”
The application is directed to an improved low-sodium salt that attaches to a bulk carrier with enhanced electrostatic force, to help increase adhesion to a variety of food surfaces. MicroSalt® is a proprietary salt made with micron-size salt particles that dissolve in the mouth significantly faster than regular salt, delivering an increased sensation of saltiness with much less salt, and as a result approximately 50% less sodium.
Victor Hugo Manzanilla, CEO of Salarius said, “In addition to MicroSalt’s current disruptive technology which helps consumers reduce sodium consumption, we have taken a step forward to help solve a critical challenge for snack manufacturers: improving salt adhesion to their food during shipping and display.”
Snack food manufacturers have continued to face major problems with inconsistent flavour and product waste, possibly losing loyal customers over time and increased manufacturing costs, from having to add more salt to each package to over-compensate for settling. By the time consumers purchase and actually open bags of salty snack foods, often inconsistent salt flavour occurs due to poor salt adhesion, with the wasted salt ending up at the bottom of the bag.
Benchmark Hlgs PLC (BMK) 36.50p £290.34m
Benchmark, the aquaculture health, nutrition and genetics business today provides the following Q3 trading update.
The Company has continued to face challenging conditions in the global shrimp and Mediterranean seabass/bream markets, as outlined in its half year results in June 2019, which has impacted sales volumes in Advanced Nutrition. Additionally, the Company is experiencing a reduced contribution from trials of certain pre-license pipeline products within Animal Health, as a result of making good progress towards satisfactorily concluding trials with fewer treatments than expected, and from delays in commencing trials in several territories.
The Company’s expectations of the revenue and profit mix for the full year have also changed. The Company is actively progressing its programme of operational and structural efficiencies, including key commercial licensing deals for its non-core animal vaccines, which, if completed this financial year, are expected to substantially offset the negative variance referred to above. However, there is a risk to the delivery of these deals within the current financial year.
Notwithstanding these short-term challenges, the Board believes that the Company is well positioned in its markets and the opportunities for its existing products and those coming from its pipeline are strong. The Company continues to progress delivery of its five year strategy to drive future growth and profitability.
Marlowe PLC (MRL) 451p £206m
Marlowe plc (“Marlowe” or the “Group”), the specialist services group focused on developing companies which assure safety and regulatory compliance, announces that it has acquired Quantum Compliance incorporated as Quantum Risk Management Limited, for an initial consideration of £4.0 m.
Founded in 2003, Quantum is a leading provider of health and safety consultancy services to commercial organisations across the UK. Quantum conducts health & safety audit and consultancy services for approximately 8,000 commercial properties each year, providing specialist advice on managing health and safety risks and ensuring compliance with a wide variety of health & safety regulations.
For the year to 30 June 2018, Quantum generated revenues of £4.5m and statutory profit before tax of £0.5m. At 30 June 2018, Quantum had net assets of £1.0m. Quantum’s revenues grew at a compound rate of 18% between 2016 and 2018. The total enterprise value will comprise an upfront cash consideration of £4.0 m and contingent consideration of up to £3.2m on the achievement of certain targets. The acquisition will be funded from existing cash and debt facilities.
Europa Oil & Gas (Holdings (EOG) 2.70p £12.01m
Europa Oil & Gas (Holdings) plc, the UK and Ireland focused oil and gas exploration, development and production company, is pleased to announce that the Irish Government has approved the Company’s application for a 12 month extension to the First Phase of Frontier Exploration Licence 2/13 (‘FEL 2/13’ or ‘the Licence’) to 4 July 2020. Europa has a 100% interest in FEL 2/13 which is located on the west flank of the South Porcupine basin and includes the Kiely prospects and the Doyle Cretaceous channel complex. The 280 m barrel Kiely East prospect is the top ranked prospect on the Licence.
The next steps for the Licence include integration of recently purchased CREAN 3D seismic data with particular focus on mapping the extension of Kiely East into open acreage to the south of the Licence. A site survey application for a drilling location on Kiely East is in process. FEL 2/13 is one of six offshore Ireland licences held by Europa which potentially hold gross mean un-risked prospective resources of 6.4 billion barrels oil equivalent and 1.5 tcf gas.
Cambridge Cognition (COG) 63.00p £15m
Cambridge Cognition Holdings plc (AIM: COG), which delivers digital solutions for optimising cognitive assessment, is pleased to announce its expansion into the Chinese market with the Company’s Cambridge Neuropsychological Test Automated Battery (“CANTAB”) computerised assessments. This move strengthens the Company’s global position, having announced a major opportunity in India earlier this year.
CANTAB are world-renowned assessments that accurately measure all areas of cognition. With over 2,200 peer-reviewed publications describing the use of CANTAB tests in both research and clinical trials, the Company believes CANTAB is the gold-standard in cognitive assessments. To make these available for the Chinese market, Cambridge Cognition have developed task variants in the key spoken (Cantonese and Mandarin) and written (Chinese simplified) languages.
To support Chinese companies and global studies collecting data in China, Cambridge Cognition is establishing a secure cloud infrastructure, using Amazon Web Services, in a data centre in China to enable straight-forward compliance with China’s scientific data transfer regulations.
On the strength of these developments, Cambridge Cognition has already signed a recurring annual contract with Fudan University, Shanghai, which is ranked in the top 5 Chinese universities.
SimiGon Limited (SIM) 9.25p £4.45m
SimiGon, Ltd. (LSE: SIM), a global leader in modelling, simulation and training solutions, is pleased to announce that it was awarded an additional United States Air Force contract to provide Virtual Reality (VR) Solutions for Vance Air Force Base.
This contract further strengthens SimiGon’s position in providing Virtual and Mixed Reality technologies for training.
Ironveld PLC (IRON) 1.02p £4.91m
Ironveld plc, the owner of a High Purity Iron (“HPI”), vanadium and titanium project located on the Northern Limb of the Bushveld Complex in Limpopo Province, South Africa, is pleased to announce that as part of the strategic review of its mining assets announced on 2 July 2019, the Company has entered into confidentiality agreements with several parties interested in potentially making an offer to purchase all or part of the Company’s assets. Ironveld is currently in the process of providing such parties with further information on the Company’s assets and access to the Company’s site, management and advisers.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.